Identification of a novel series of benzimidazoles as potent and selective antagonists of the human melanocortin-4 receptor.

Bioorg Med Chem Lett

Department of Medicinal Chemistry, Ipsen Research Laboratories, Institut Henri Beaufour, 5 Avenue du Canada, 91966 Les Ulis Cedex, France.

Published: August 2007

A novel series of benzimidazoles was identified and optimized, leading to the discovery of potent and selective antagonists of the human melanocortin-4 receptor. In addition, compound 5i was shown to cross the blood-brain barrier after intravenous dosing in rats.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2007.06.010DOI Listing

Publication Analysis

Top Keywords

novel series
8
series benzimidazoles
8
potent selective
8
selective antagonists
8
antagonists human
8
human melanocortin-4
8
melanocortin-4 receptor
8
identification novel
4
benzimidazoles potent
4
receptor novel
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!